Communiqués Alcon Inc.

Actions

ALC

CH0432492467

Marché Fermé - Swiss Exchange Autres places de cotation 17:30:41 31/05/2024			Varia. 5j.	Varia. 1 janv.
80,34 ^CHF	+0,17%		-2,05%	+22,39%

29/05	Le Suisse Alcon inaugure son siège au Moyen-Orient en Arabie Saoudite	MT
22/05	ALCON INC. : UBS à l'achat	ZM

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Alcon : First Quarter 2024 Earnings Conference Call Regulatory Filing	14/05	PU
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health	13/05	BU
Alcon Announces Results of 2024 Annual General Meeting	08/05	BU
Alcon : 2024 Annual General Meeting AGM Frequently Asked Questions English	08/05	PU
Alcon : 2024 Annual General Meeting AGM Frequently Asked Questions Français	08/05	PU
Alcon Publishes Agenda for 2024 Annual General Meeting	07/04	BU
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04	AQ
Alcon : Terry Kim, MD, Joins Alcon as Chief Medical Officer and Head of Global Medical Safety	26/03	PU
Alcon : Terry Kim, MD, Joins Alcon as Chief Medical Officer and Head of Global Medical Safety	26/03	PU
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India	12/03	BU
Alcon - Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone	07/03	AQ
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone	06/03	BU
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone	06/03	BU
Alcon Loses Sight Of Dismissal In Suit Over Its Eye Drops' "30 Day Supply" Claims	04/03	AQ
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023	27/02	BU
Alcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytie	01/02	BU
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye	09/01	BU
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference	27/12	BU
Alcon Reports Third Quarter 2023 Results	14/11	BU
Alcon : Third Quarter 2023 Earnings Conference Call Regulatory Filing	14/11	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

ALCON : Les marchés se réjouissent du résultat positif au 1er trimestre ; révision à la hausse des prévisions

Le 14 mai 2024 à 17:50

Alcon Inc. : visibilité optimale sur l’avenir

Le 26 mai 2023 à 17:26